$1.30
0.1311.11%
At Close: -
$1.35
0.053.85%
After Hours: 4:14 PM EDT
15 minutes delayed
Nektar Therapeutics: Insider buying and selling updated today.
Jun 14, 2024 | ROBERT CHESS | — | -19.5K | $1.20 | -$23.40K | SELL | -7.04% | 257.373K | Jun 14 | View |
May 20, 2024 | HOWARD ROBIN | PRESIDENT & CEO | -16.65K | $1.75 | -$29.14K | SELL | -1.89% | 863.649K | May 17 | View |
May 20, 2024 | Jonathan Zalevsky | CHIEF R&D OFFICER | -7.355K | $1.75 | -$12.87K | SELL | -2.78% | 257.67K | May 17 | View |
May 20, 2024 | Mark A. Wilson | CHIEF LEGAL OFFICER | -6.26K | $1.75 | -$10.96K | SELL | -2.64% | 230.414K | May 17 | View |
May 13, 2024 | Deep Track Capital LPDeep Track Biotechnology Master Fund LtdDAVID KROIN | — | -56K | $1.78 | -$99.63K | SELL | -0.30% | 18.344M | May 10 | View |
Feb 22, 2024 | Jonathan Zalevsky | CHIEF R&D OFFICER | -9.014K | $0.68 | -$6.13K | SELL | -3.29% | 265.025K | Feb 20 | View |
Feb 22, 2024 | Mark A. Wilson | CHIEF LEGAL OFFICER | -7.606K | $0.68 | -$5.17K | SELL | -3.11% | 236.674K | Feb 20 | View |
Feb 22, 2024 | HOWARD ROBIN | PRESIDENT & CEO | -20.033K | $0.68 | -$13.62K | SELL | -2.23% | 880.299K | Feb 20 | View |
Nov 20, 2023 | Jonathan Zalevsky | CHIEF R&D OFFICER | -9.646K | $0.49 | -$4.73K | SELL | -3.40% | 274.039K | Nov 17 | View |
Nov 20, 2023 | Mark A. Wilson | CHIEF LEGAL OFFICER | -7.179K | $0.49 | -$3.52K | SELL | -2.86% | 243.78K | Nov 17 | View |
Nov 20, 2023 | HOWARD ROBIN | PRESIDENT & CEO | -19.877K | $0.49 | -$9.74K | SELL | -2.16% | 900.332K | Nov 17 | View |
Sep 20, 2023 | Myriam Curet | DIRECTOR | -4.359K | $0.69 | -$3.01K | SELL | -13.72% | 27.418K | Sep 18 | View |
Sep 20, 2023 | ROBERT CHESS | DIRECTOR | -10.2K | $0.67 | -$6.83K | SELL | -3.55% | 276.873K | Sep 22 | View |
Sep 20, 2023 | Robert Jeffrey Ajer | DIRECTOR | -4.359K | $0.69 | -$3.01K | SELL | -11.32% | 34.153K | Sep 18 | View |
Aug 17, 2023 | Jonathan Zalevsky | CHIEF R&D OFFICER | -9.703K | $0.78 | -$7.57K | SELL | -3.31% | 283.685K | Aug 16 | View |
Aug 17, 2023 | Mark A. Wilson | CHIEF LEGAL OFFICER | -7.221K | $0.78 | -$5.63K | SELL | -2.80% | 250.959K | Aug 16 | View |
Aug 17, 2023 | HOWARD ROBIN | PRESIDENT & CEO | -19.998K | $0.78 | -$15.60K | SELL | -2.13% | 920.209K | Aug 16 | View |
Jun 15, 2023 | ROY WHITFIELD | DIRECTOR | -30K | $0.57 | -$17.10K | SELL | -11.27% | 236.25K | Jun 14 | View |
May 17, 2023 | Jonathan Zalevsky | CHIEF R&D OFFICER | -9.791K | $0.72 | -$7.05K | SELL | -3.23% | 293.388K | May 16 | View |
May 17, 2023 | Mark A. Wilson | CHIEF LEGAL OFFICER | -7.543K | $0.72 | -$5.43K | SELL | -2.84% | 257.68K | May 16 | View |
May 17, 2023 | HOWARD ROBIN | PRESIDENT & CEO | -20.361K | $0.72 | -$14.66K | SELL | -2.12% | 940.207K | May 16 | View |
Feb 17, 2023 | Jonathan Zalevsky | CHIEF R&D OFFICER | -10.484K | $3.00 | -$31.45K | SELL | -3.34% | 303.179K | Feb 16 | View |
Feb 17, 2023 | Mark A. Wilson | CHIEF LEGAL OFFICER | -8.275K | $3.00 | -$24.82K | SELL | -3.03% | 265.223K | Feb 16 | View |
Feb 17, 2023 | Jillian Thomsen | CHIEF FINANCIAL OFFICER | -10.267K | $3.00 | -$30.80K | SELL | -3.17% | 313.497K | Feb 16 | View |
Feb 17, 2023 | HOWARD ROBIN | PRESIDENT & CEO | -19.635K | $3.00 | -$58.91K | SELL | -2.00% | 960.568K | Feb 16 | View |
Nov 18, 2022 | Jonathan Zalevsky | CHIEF R&D OFFICER | -13.46K | $3.57 | -$48.05K | SELL | -4.11% | 313.663K | Nov 16 | View |
Nov 18, 2022 | Mark A. Wilson | CHIEF LEGAL OFFICER | -8.69K | $3.57 | -$31.02K | SELL | -3.09% | 272.498K | Nov 16 | View |
Nov 18, 2022 | Jillian Thomsen | CHIEF FINANCIAL OFFICER | -11.095K | $3.57 | -$39.61K | SELL | -3.31% | 323.764K | Nov 16 | View |
Nov 18, 2022 | HOWARD ROBIN | PRESIDENT & CEO | -38.014K | $3.57 | -$135.71K | SELL | -3.73% | 980.203K | Nov 16 | View |
Sep 26, 2022 | Myriam Curet | DIRECTOR | -4.198K | $3.16 | -$13.27K | SELL | -11.67% | 31.777K | Sep 23 | View |
Sep 26, 2022 | Robert Jeffrey Ajer | DIRECTOR | -4.198K | $3.16 | -$13.27K | SELL | -9.83% | 38.512K | Sep 23 | View |
Sep 26, 2022 | ROBERT CHESS | DIRECTOR | -5.1K | $3.19 | -$16.27K | SELL | -1.95% | 256.179K | Sep 22 | View |
Sep 14, 2022 | KARIN EASTHAM | DIRECTOR | -21.267K | $3.61 | -$76.77K | SELL | -62.00% | 13.033K | Sep 13 | View |
Aug 19, 2022 | Jonathan Zalevsky | CHIEF R&D OFFICER | -73.716K | $4.65 | -$342.78K | SELL | -18.39% | 327.123K | Aug 18 | View |
Aug 17, 2022 | Jonathan Zalevsky | CHIEF R&D OFFICER | 124.44K | $4.76 | -$50.27K | GRANT | 45.02% | 400.839K | Aug 15 - Aug 16 | View |
Aug 17, 2022 | Mark A. Wilson | SVP & GENERAL COUNSEL | 162.749K | $4.76 | -$15.18K | GRANT | 137.41% | 281.188K | Aug 15 - Aug 16 | View |
Aug 17, 2022 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 163.932K | $4.76 | -$9.55K | GRANT | 95.91% | 334.859K | Aug 15 - Aug 16 | View |
Aug 17, 2022 | HOWARD ROBIN | PRESIDENT & CEO | 396.866K | $4.76 | -$65.49K | GRANT | 63.87% | 1.018217M | Aug 15 - Aug 16 | View |
May 17, 2022 | Jonathan Zalevsky | CHIEF R&D OFFICER | 2.277K | $3.95 | -$85.61K | GRANT | 0.83% | 276.399K | May 15 - May 16 | View |
May 17, 2022 | Mark A. Wilson | SVP & GENERAL COUNSEL | -3.136K | $3.95 | -$12.39K | SELL | -2.59% | 117.939K | May 16 | View |
May 17, 2022 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 5.109K | $3.95 | -$23.07K | GRANT | 3.09% | 170.427K | May 15 - May 16 | View |
May 17, 2022 | HOWARD ROBIN | PRESIDENT & CEO | 31.921K | $3.95 | -$144.29K | GRANT | 5.42% | 621.351K | May 15 - May 16 | View |
May 17, 2022 | JOHN NORTHCOTT | SVP & CHIEF COMMERCIAL OFFICER | -4.592K | $3.95 | -$18.14K | SELL | -2.02% | 223.21K | May 16 | View |
May 17, 2022 | Gil Labrucherie | SVP, COO & CFO | 11.302K | $3.95 | -$68.92K | GRANT | 3.75% | 312.905K | May 15 - May 16 | View |
Feb 18, 2022 | Jonathan Zalevsky | CHIEF R&D OFFICER | -10.912K | $10.95 | -$119.49K | SELL | -3.83% | 274.122K | Feb 16 | View |
Feb 18, 2022 | Mark A. Wilson | SVP & GENERAL COUNSEL | -3.661K | $10.95 | -$40.09K | SELL | -2.93% | 121.075K | Feb 16 | View |
Feb 18, 2022 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -2.363K | $10.95 | -$25.87K | SELL | -1.41% | 165.318K | Feb 16 | View |
Feb 18, 2022 | HOWARD ROBIN | PRESIDENT & CEO | -12.48K | $10.95 | -$136.66K | SELL | -2.07% | 589.43K | Feb 16 | View |
Feb 18, 2022 | JOHN NORTHCOTT | SVP & CHIEF COMMERCIAL OFFICER | -4.852K | $10.95 | -$53.13K | SELL | -2.09% | 227.802K | Feb 16 | View |
Feb 18, 2022 | Gil Labrucherie | SVP, COO & CFO | -7.579K | $10.95 | -$82.99K | SELL | -2.45% | 301.603K | Feb 16 | View |
Nov 18, 2021 | Gil Labrucherie | SVP, COO & CFO | -24.149K | $13.10 | -$316.39K | SELL | -8.60% | 256.682K | Nov 16 - Nov 18 | View |
Nov 17, 2021 | Jonathan Zalevsky | CHIEF R&D OFFICER | 19.281K | $13.16 | -$274.64K | GRANT | 9.06% | 232.084K | Nov 15 - Nov 16 | View |
Nov 17, 2021 | Mark A. Wilson | SVP & GENERAL COUNSEL | 13.536K | $13.16 | -$86.38K | GRANT | 18.57% | 86.436K | Nov 15 - Nov 16 | View |
Nov 17, 2021 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 8.159K | $13.16 | -$88.71K | GRANT | 5.92% | 145.981K | Nov 15 - Nov 16 | View |
Nov 17, 2021 | HOWARD ROBIN | PRESIDENT & CEO | 51.327K | $13.16 | -$562.89K | GRANT | 12.09% | 475.86K | Nov 15 - Nov 16 | View |
Nov 17, 2021 | JOHN NORTHCOTT | SVP & CHIEF COMMERCIAL OFFICER | -6.061K | $13.16 | -$79.76K | SELL | -3.02% | 194.854K | Nov 16 | View |
Sep 24, 2021 | Myriam Curet | DIRECTOR | 6.535K | $17.78 | -$65.16K | GRANT | 33.97% | 25.775K | Sep 22 | View |
Sep 24, 2021 | ROBERT CHESS | DIRECTOR | 5.6K | $17.94 | -$82.52K | GRANT | 2.03% | 281.973K | Sep 22 | View |
Sep 24, 2021 | Robert Jeffrey Ajer | DIRECTOR | 6.535K | $17.78 | -$65.16K | GRANT | 25.16% | 32.51K | Sep 22 | View |
Sep 10, 2021 | ROBERT CHESS | DIRECTOR | 0 | $14.91 | -$40.42K | SELL-OPTIONS | 0.00% | 276.373K | Sep 08 - Sep 09 | View |
Aug 18, 2021 | Jonathan Zalevsky | CHIEF R&D OFFICER | -7.662K | $13.83 | -$105.97K | SELL | -3.48% | 212.803K | Aug 16 | View |
Aug 18, 2021 | Mark A. Wilson | SVP & GENERAL COUNSEL | -1.91K | $13.83 | -$26.42K | SELL | -2.55% | 72.9K | Aug 16 | View |
Aug 18, 2021 | HOWARD ROBIN | PRESIDENT & CEO | -11.515K | $13.83 | -$159.25K | SELL | -2.64% | 424.533K | Aug 16 | View |
Aug 18, 2021 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -13.339K | $13.83 | -$184.48K | SELL | -8.82% | 137.822K | Aug 16 | View |
Aug 18, 2021 | JOHN NORTHCOTT | SVP & CHIEF COMMERCIAL OFFICER | -6.192K | $13.83 | -$85.64K | SELL | -2.99% | 200.915K | Aug 16 | View |
Aug 18, 2021 | Gil Labrucherie | SVP, COO & CFO | -10.867K | $13.76 | -$149.48K | SELL | -4.33% | 240.231K | Aug 16 - Aug 17 | View |
Jul 22, 2021 | ROBERT CHESS | DIRECTOR | 0 | $15.30 | -$17.20K | SELL-OPTIONS | 0.00% | 280.573K | Jul 20 - Jul 22 | View |
May 19, 2021 | Jonathan Zalevsky | CHIEF R&D OFFICER | -31.111K | $18.30 | -$569.33K | SELL | -11.69% | 235.065K | May 17 | View |
May 19, 2021 | Mark A. Wilson | SVP & GENERAL COUNSEL | -1.917K | $18.30 | -$35.08K | SELL | -2.50% | 74.81K | May 17 | View |
May 19, 2021 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -13.391K | $18.30 | -$245.06K | SELL | -8.14% | 151.161K | May 17 | View |
May 19, 2021 | HOWARD ROBIN | PRESIDENT & CEO | -11.56K | $18.30 | -$211.55K | SELL | -2.58% | 436.048K | May 17 | View |
May 19, 2021 | JOHN NORTHCOTT | SVP & CHIEF COMMERCIAL OFFICER | -6.085K | $18.30 | -$111.36K | SELL | -2.85% | 207.107K | May 17 | View |
May 19, 2021 | Gil Labrucherie | SVP, COO & CFO | -7.898K | $18.30 | -$144.53K | SELL | -3.05% | 251.098K | May 17 | View |
May 14, 2021 | ROBERT CHESS | DIRECTOR | 0 | $16.57 | -$44.32K | SELL-OPTIONS | 0.00% | 280.573K | May 12 | View |
Apr 16, 2021 | ROBERT CHESS | DIRECTOR | 0 | $16.39 | -$41.44K | SELL-OPTIONS | 0.00% | 280.573K | Apr 14 | View |
Feb 18, 2021 | Jonathan Zalevsky | CHIEF R&D OFFICER | -24.141K | $22.37 | -$540.03K | SELL | -8.32% | 266.176K | Feb 16 | View |
Feb 18, 2021 | Mark A. Wilson | SVP & GENERAL COUNSEL | -2.173K | $22.37 | -$48.61K | SELL | -2.75% | 76.727K | Feb 16 | View |
Feb 18, 2021 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -11.705K | $22.37 | -$261.84K | SELL | -6.64% | 164.552K | Feb 16 | View |
Feb 18, 2021 | HOWARD ROBIN | PRESIDENT & CEO | -11.495K | $22.37 | -$257.14K | SELL | -2.50% | 447.608K | Feb 16 | View |
Feb 18, 2021 | JOHN NORTHCOTT | SVP & CHIEF COMMERCIAL OFFICER | -15.358K | $22.37 | -$343.56K | SELL | -6.72% | 213.192K | Feb 16 | View |
Feb 18, 2021 | Gil Labrucherie | SVP, COO & CFO | -7.977K | $22.37 | -$178.45K | SELL | -2.99% | 258.996K | Feb 16 | View |
Feb 04, 2021 | Mark A. Wilson | SVP & GENERAL COUNSEL | -10.688K | $14.13 | -$150.97K | SELL | -11.93% | 78.9K | Feb 03 | View |
Feb 04, 2021 | HOWARD ROBIN | PRESIDENT & CEO | 0 | $14.36 | -$5.01M | SELL-OPTIONS | 0.00% | 459.103K | Feb 02 - Feb 04 | View |
Feb 04, 2021 | Gil Labrucherie | SVP, COO & CFO | 0 | $14.33 | -$1.66M | SELL-OPTIONS | 0.00% | 266.973K | Feb 02 - Feb 04 | View |
Jan 29, 2021 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0 | $13.71 | -$736.50K | SELL-OPTIONS | 0.00% | 176.257K | Jan 28 | View |
Dec 17, 2020 | Curet Myriam | — | -1.56K | $17.82 | -$27.80K | SELL | -7.50% | 19.24K | Dec 15 | View |
Nov 25, 2020 | Jonathan Zalevsky | — | -16.38K | $16.40 | -$268.63K | SELL | -6.14% | 250.317K | Nov 23 | View |
Nov 18, 2020 | Jonathan Zalevsky | — | -29.618K | $16.93 | -$501.43K | SELL | -10.00% | 266.697K | Nov 16 | View |
Nov 18, 2020 | Mark A. Wilson Attorney-in-Fact | — | -1.539K | $16.93 | -$26.06K | SELL | -2.99% | 49.85K | Nov 16 | View |
Nov 18, 2020 | Jillian Thomsen | — | -11.976K | $16.93 | -$202.75K | SELL | -6.97% | 159.757K | Nov 16 | View |
Nov 18, 2020 | HOWARD ROBIN | — | -11.975K | $16.93 | -$202.74K | SELL | -3.29% | 352.453K | Nov 16 | View |
Nov 18, 2020 | Gil Labrucherie | — | -8.276K | $16.93 | -$140.11K | SELL | -3.52% | 226.973K | Nov 16 | View |
Sep 30, 2020 | Robert Jeffrey Ajer | — | -3.25K | $17.25 | -$56.06K | SELL | -11.12% | 25.975K | Sep 28 | View |
Sep 25, 2020 | ROBERT CHESS | — | -5.5K | $17.75 | -$97.63K | SELL | -1.92% | 280.573K | Sep 25 | View |
Sep 21, 2020 | Gil Labrucherie | — | -2K | $19.96 | -$39.92K | SELL | -0.84% | 235.249K | Sep 17 | View |
Sep 21, 2020 | Robert Jeffrey Ajer | — | -2.25K | $19.74 | -$44.41K | SELL | -10.06% | 20.125K | Sep 21 | View |
Sep 10, 2020 | ROBERT CHESS | — | 0 | $13.89 | -$74.32K | OPTION EXERCISE | 0.00% | 276.973K | Sep 08 | View |
Aug 19, 2020 | Jonathan Zalevsky | — | -26.2K | $19.67 | -$515.35K | SELL | -8.12% | 296.315K | Aug 17 | View |
Aug 19, 2020 | Mark A. Wilson Attorney-in-Fact | — | -1.529K | $19.67 | -$30.08K | SELL | -2.89% | 51.389K | Aug 17 | View |
Aug 19, 2020 | Jillian Thomsen | — | -1.367K | $19.67 | -$26.89K | SELL | -0.79% | 171.733K | Aug 17 | View |
Aug 19, 2020 | HOWARD ROBIN | — | -11.885K | $19.67 | -$233.78K | SELL | -3.16% | 364.428K | Aug 17 | View |
Aug 19, 2020 | Gil Labrucherie | — | -8.245K | $19.67 | -$162.20K | SELL | -3.36% | 237.249K | Aug 17 - Aug 18 | View |
Jul 10, 2020 | SCOTT GREER | — | 24.991K | $17.12 | -$5.63K | OPTION EXERCISE | 16.49% | 176.574K | Jul 09 | View |
Jul 10, 2020 | ROBERT CHESS | — | 0 | $16.91 | -$122.72K | OPTION EXERCISE | 0.00% | 276.973K | Jul 08 | View |
May 20, 2020 | Jonathan Zalevsky | — | -4.558K | $22.51 | -$102.60K | SELL | -1.39% | 322.515K | May 18 | View |
May 20, 2020 | Mark A. Wilson Attorney-in-Fact | — | -1.529K | $22.51 | -$34.42K | SELL | -2.83% | 52.418K | May 18 | View |
May 20, 2020 | Jillian Thomsen | — | -1.367K | $22.51 | -$30.77K | SELL | -0.79% | 172.719K | May 18 | View |
May 20, 2020 | HOWARD ROBIN | — | -8.968K | $22.51 | -$201.87K | SELL | -2.33% | 376.313K | May 18 | View |
May 20, 2020 | Gil Labrucherie | — | -7.727K | $22.54 | -$174.15K | SELL | -3.05% | 245.494K | May 18 - May 19 | View |
Apr 17, 2020 | ROBERT CHESS | — | -16K | $13.81 | -$220.93K | OPTION EXERCISE | -5.46% | 276.973K | Apr 15 | View |
Mar 13, 2020 | ROBERT CHESS | — | -16K | $13.01 | -$208.24K | OPTION EXERCISE | -5.46% | 276.973K | Mar 11 | View |
Feb 20, 2020 | Jonathan Zalevsky | — | -4.774K | $22.35 | -$106.70K | SELL | -1.44% | 327.073K | Feb 18 | View |
Feb 20, 2020 | Jillian Thomsen | — | -1.394K | $22.35 | -$31.16K | SELL | -0.79% | 174.086K | Feb 18 | View |
Feb 20, 2020 | HOWARD ROBIN | — | -8.448K | $22.35 | -$188.81K | SELL | -2.15% | 385.281K | Feb 18 | View |
Feb 20, 2020 | Gil Labrucherie | — | -5.938K | $22.35 | -$132.71K | SELL | -2.29% | 253.221K | Feb 18 | View |
Feb 14, 2020 | ROBERT CHESS | — | -16K | $16.37 | -$261.92K | OPTION EXERCISE | -5.46% | 276.973K | Feb 12 | View |
Feb 07, 2020 | Jillian Thomsen | — | 0 | $15.00 | -$583.88K | OPTION EXERCISE | 0.00% | 175.48K | Feb 06 | View |
Nov 20, 2019 | Jonathan Zalevsky | CHIEF R&D OFFICER | -3.96K | $17.97 | -$71.16K | SELL | -1.34% | 291.697K | Nov 18 | View |
Nov 20, 2019 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -2.713K | $17.97 | -$48.75K | SELL | -1.66% | 160.441K | Nov 18 | View |
Nov 20, 2019 | HOWARD ROBIN | PRESIDENT & CEO | -13.556K | $17.97 | -$243.60K | SELL | -4.33% | 299.629K | Nov 18 | View |
Nov 20, 2019 | Gil Labrucherie | SVP, COO & CFO | -8.863K | $17.97 | -$159.27K | SELL | -3.89% | 219.009K | Nov 18 | View |
Nov 15, 2019 | Gil Labrucherie | SVP, COO & CFO | 0 | $13.50 | -$314.50K | SELL-OPTIONS | 0.00% | 227.872K | Nov 13 | View |
Oct 17, 2019 | HOWARD ROBIN | PRESIDENT & CEO | 0 | $12.29 | -$1.02M | SELL-OPTIONS | 0.00% | 313.185K | Oct 15 - Oct 17 | View |
Oct 17, 2019 | Gil Labrucherie | SVP, COO & CFO | 0 | $11.52 | -$215.50K | SELL-OPTIONS | 0.00% | 227.872K | Oct 15 | View |
Oct 02, 2019 | Lutz Lingnau | DIRECTOR | -3K | $17.84 | -$53.52K | SELL | -10.10% | 26.7K | Sep 27 | View |
Oct 01, 2019 | Robert Jeffrey Ajer | DIRECTOR | -2.375K | $18.06 | -$42.89K | SELL | -9.60% | 22.375K | Sep 30 | View |
Oct 01, 2019 | ROBERT CHESS | DIRECTOR | -4K | $17.99 | -$71.96K | SELL | -1.42% | 276.973K | Sep 27 | View |
Sep 24, 2019 | Robert Jeffrey Ajer | DIRECTOR | -2.25K | $20.24 | -$45.54K | SELL | -10.98% | 18.25K | Sep 20 | View |
Sep 18, 2019 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | 0 | $13.87 | -$332.75K | SELL-OPTIONS | 0.00% | 152.872K | Sep 16 | View |
Sep 09, 2019 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | 15K | $17.28 | $259.20K | BUY | 16.19% | 107.668K | Sep 05 | View |
Aug 19, 2019 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -1.809K | $18.15 | -$32.83K | SELL | -1.10% | 163.154K | Aug 16 | View |
Aug 19, 2019 | HOWARD ROBIN | PRESIDENT & CEO | -12.551K | $18.15 | -$227.80K | SELL | -4.24% | 283.185K | Aug 16 | View |
Aug 19, 2019 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -3.819K | $18.15 | -$69.31K | SELL | -2.29% | 162.759K | Aug 16 | View |
Aug 19, 2019 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | -5.063K | $18.15 | -$91.89K | SELL | -3.96% | 122.872K | Aug 16 | View |
Aug 19, 2019 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | -3.245K | $18.15 | -$58.90K | SELL | -3.38% | 92.668K | Aug 16 | View |
Aug 16, 2019 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | 0 | $12.50 | -$264.50K | SELL-OPTIONS | 0.00% | 127.935K | Aug 14 | View |
Jul 25, 2019 | HOWARD ROBIN | PRESIDENT & CEO | 0 | $19.25 | -$2.41M | SELL-OPTIONS | 0.00% | 295.736K | Jul 23 - Jul 25 | View |
Jul 12, 2019 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | 0 | $20.89 | -$684.00K | SELL-OPTIONS | 0.00% | 127.935K | Jul 10 | View |
Jul 10, 2019 | Lutz Lingnau | DIRECTOR | 0 | $21.94 | -$253.90K | SELL-OPTIONS | 0.00% | 23.2K | Jul 08 | View |
Browse insider trades on all stocks.